Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback.
暂无分享,去创建一个
Floyd J Fowler | David F Ransohoff | D. Ransohoff | F. J. Fowler | M. McNaughton Collins | Mary McNaughton Collins
[1] J. Cerhan,et al. Prostate Cancer Trends 1973-1995, SEER Program National Cancer Institute. , 1999 .
[2] C G Chute,et al. Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. , 1995, JAMA.
[3] J. Goodwin. Geriatrics and the limits of modern medicine. , 1999, The New England journal of medicine.
[4] B A Miller,et al. The role of increasing detection in the rising incidence of prostate cancer. , 1995, JAMA.
[5] A. Zietman,et al. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. , 2000, JAMA.
[6] R A Stephenson,et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. , 2000, Journal of the National Cancer Institute.
[7] J. Richie,et al. Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. , 1997, Journal of the National Cancer Institute.
[8] David Haber,et al. Guide to clinical preventive services: a challenge to physician resourcefulness , 1993 .
[9] D. Sulmasy,et al. What should men know about prostate-specific antigen screening before giving informed consent? , 1998, The American journal of medicine.
[10] Campbell Gd,et al. American College of Physicians , 1974, Definitions.
[11] Lisa M. Schwartz,et al. The U.S. Postal Service and cancer screening--stamps of approval? , 1999, The New England journal of medicine.
[12] M. Owings,et al. Detailed diagnoses and procedures, National Hospital Discharge Survey, 1997. , 1999, Vital and health statistics. Series 13, Data from the National Health Survey.
[13] J. Oesterling,et al. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists. , 1998, The American journal of medicine.
[14] R. Volk,et al. A randomized controlled trial of shared decision making for prostate cancer screening. , 1999, Archives of family medicine.
[15] Roberts Rg,et al. PSA screening for asymptomatic prostate cancer: truth in advertising. , 1993 .
[16] Louis R Kavoussi,et al. Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. , 1993, Urology.
[17] M. Barry,et al. Patient-re ported complications and follow-up treatment after radical prostatectomy , 1993 .
[18] M. Barry,et al. Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] Juni Palmgren,et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. , 2002, The New England journal of medicine.
[20] M. Barry,et al. Involving patients in medical decisions: how can physicians do better? , 1999, JAMA.
[21] R A Stephenson,et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. , 2000, JAMA.
[22] Christopher Coley,et al. CLINICAL GUIDELINE: PART 1: Early Detection of Prostate Cancer: Part I , 1997, Annals of Internal Medicine.
[23] M. Barry,et al. Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey. , 1995, Urology.
[24] CONTROVERSY IN THE DETECTION OF DISEASE , 1975, The Lancet.
[25] P. Scardino,et al. Early detection of prostate cancer. , 1989, The Urologic clinics of North America.
[26] J. Schorling,et al. The impact of informed consent on patient interest in prostate-specific antigen screening. , 1996, Archives of internal medicine.
[27] Taylor Murray,et al. Cancer statistics, 2000 , 2000, CA: a cancer journal for clinicians.